SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-003090
Filing Date
2018-02-07
Accepted
2018-02-07 16:06:04
Documents
1
Period of Report
2018-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7608
  Complete submission text file 0000899243-18-003090.txt   9105
Mailing Address C/O AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300 BRISBANE CA 94005-1884
Business Address
Sheehy Douglas T. (Reporting) CIK: 0001488637 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37519 | Film No.: 18581156

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Issuer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations